RISE study
We are looking for children and teens who are diagnosed with Crohn’s disease (CD) to take part in a research study for an investigational drug. The study will evaluate the safety and effectiveness of an investigational drug to manage CD symptoms in children.
- Children and teens between the ages of 2 to <18 years of age may be eligible to participate.
- Participants will receive study drug and all related study procedures that are required at no cost.
- Reimbursement for travel may be available.
- To see if the is right for your child, please contact us.
Location: MNGI Digestive Health, Northeast Minneapolis Clinic
Physician Investigator: Ramalingam Arumugam, M.D.
Study Coordinator: Roxie Strehlo
AbbVie M14-671
We are looking for children and teens who have been diagnosed with Crohn’s Disease (CD) to take part in a research study for an investigational medication. The study will evaluate the safety and effectiveness of an investigational oral drug to manage CD symptoms in children.
Your child or teen may qualify if they:
- Are 2 to <18 years of age.
- Weigh at least 22 lbs.
- Have been diagnosed with Crohn’s Disease.
Participants will receive the study medication and all related study procedures that are required at no cost. To see if this study is right for your child, please contact us.
Location: MNGI Digestive Health, Northeast Minneapolis Clinic
Physician Investigator: Ramalingam Arumugam, M.D.
Study Coordinator: Naomi Mugarura